1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. EKIMAS Corporation
  6. News
  7. All News
    ASNB   US28265K2050

EKIMAS CORPORATION

(ASNB)
  Report
Delayed OTC Markets  -  05/26 10:39:34 am EDT
1.700 USD   -2.86%
04/12EKIMAS CORP : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
03/21EKIMAS CORP : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Changes in Control or Registrant, Financial Statements and Exhibits (form 8-K)
AQ
01/14EKIMAS CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about EKIMAS CORPORATION
04/12EKIMAS CORP : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu..
AQ
03/21EKIMAS CORP : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu..
AQ
01/14EKIMAS CORP Management's Discussion and Analysis of Financial Condition and Results of..
AQ
01/14EKIMAS Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended..
CI
2021EKIMAS CORP Management's Discussion and Analysis of Financial Condition and Results of..
AQ
2021EKIMAS Corporation Reports Earnings Results for the Second Quarter and Six Months Ended..
CI
2021EKIMAS CORP : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu..
AQ
2021EKIMAS Corporation Announces CEO Changes
CI
2021EKIMAS Corporation Announces Director Changes
CI
2021EKIMAS : Management's Discussion and Analysis of Financial Condition and Results of Operat..
AQ
2021EKIMAS : Management's Discussion and Analysis or Plan of Operation (form 10-K)
AQ
2021EKIMAS : Management's Discussion and Analysis of Financial Condition and Results of Operat..
AQ
2021EKIMAS : Management's Discussion and Analysis of Financial Condition and Results of Operat..
AQ
2021EKIMAS : Letter from RBSM LLP to the Securities and Exchange Commission dated August 27, 2..
PU
2021EKIMAS CORP : Changes in Registrant's Certifying Accountant, Financial Statements and Exhi..
AQ
2021EKIMAS : Management's Discussion and Analysis or Plan of Operation (form 10-K)
AQ
2021Ekimas Corporation Reports Earnings Results for the Full Year Ended March 31, 2020
CI
2021EKIMAS Corporation Auditor Raises 'Going Concern' Doubt
CI
2020EKIMAS CORP : Change in Directors or Principal Officers (form 8-K)
AQ
2020EKIMAS Corporation Announces Board Changes
CI
2020EKIMAS Corporation Announces Special Cash Distribution, Payable on April 23, 2020
CI
2020EKIMAS CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020ADVANSOURCE BIOMATERIALS CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal..
AQ
2020AdvanSource Biomaterials Corp. has Changed its Name to EKIMAS Corporation
CI
2020ADVANSOURCE BIOMATERIALS : Management's Discussion and Analysis of Financial Condition and..
AQ
2020Ekimas Corporation Reports Earnings Results for the Third Quarter Ended December 31, 20..
CI
2020AdvanSource Biomaterials Corporation Announces Khristine Carroll Resigned as Executive ..
CI
2020ADVANSOURCE BIOMATERIALS CORP : Completion of Acquisition or Disposition of Assets, Change..
AQ
2020AdvanSource Biomaterials Corporation Announces Completion of the Sale of Substantially ..
GL
2020Mitsubishi Chemical Performance Polymers, Inc. completed the acquisition of substantial..
CI
2020ADVANSOURCE BIOMATERIALS CORP : Submission of Matters to a Vote of Security Holders (form ..
AQ
2019ADVANSOURCE BIOMATERIALS CORP : Entry into a Material Definitive Agreement, Financial Stat..
AQ
2019ADVANSOURCE BIOMATERIALS CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2019Mitsubishi Chemical Performance Polymers, Inc. entered into an asset purchase agreement..
CI
2019Advansource Biomaterials Corporation Reports Earnings Results for the Second Quarter En..
CI
2019Advansource Biomaterials Corporation Reports Earnings Results for the First Quarter End..
CI
2019Advansource Biomaterials Corporation Reports Earnings Results for the Full Year Ended M..
CI
2019Advansource Biomaterials Corporation Reports Earnings Results for the Third Quarter End..
CI
2018AdvanSource Biomaterials Corporation Announces Multi-Year Extension of License and Roya..
CI
2017AdvanSource Biomaterials and Medibrane Form Strategic Alliance
CI
2016ADVANSOURCE BIOMATERIALS : Reports fiscal 2016 third quarter results
PU
2015ADVANSOURCE BIOMATERIALS : Asb announces multi-year supply agreement
PU
2015ADVANSOURCE BIOMATERIALS : Engages mirus securities inc. as its strategic advisor
PU
2015ADVANSOURCE BIOMATERIALS : Asb reports fiscal 2016 second quarter results and third consec..
PU
2015ADVANSOURCE BIOMATERIALS : ASB Announces Radiography-Imaging Contract
PU
2015AdvanSource Biomaterials Corporation Announces Multi-Year Supply Agreement with Promine..
CI
2015AdvanSource Biomaterials Corporation Announces Financial Results for Second Quarter and..
CI
2015ADVANSOURCE BIOMATERIALS : Reports FY2016 First Quarter Results and Second Consecutive Qua..
PU
2015AdvanSource Biomaterials Corporation Announces Earnings Results for the First Quarter E..
CI
2014Advansource Biomaterials Corporation Announces Resignation of David Volpe as Chief Fina..
CI
2013AdvanSource Biomaterials Completes $100,000 Short-Term Financing with Shareholders and ..
CI
2013AdvanSource Biomaterials Corporation announced that it has received $0.10 million in fu..
CI
2012AdvanSource Biomaterials Corporation Announces Retirement and Resignation of Anthony J...
CI